Web Analytics
VCEL (NASDAQ) Stock Analysis | VERICEL CORP ORD – Deepscope
MARKET

Select Market Data Region

VCEL — VERICEL CORP ORD (Healthcare >> Biotechnology)

VCEL FAQ

What is VCEL's P/E ratio?

VERICEL CORP ORD (VCEL) currently trades at a P/E ratio of 62.13.

What is VCEL's ROE?

VERICEL CORP ORD reports a Return on Equity (ROE) of 6.02%.

What is VCEL's dividend yield?

VERICEL CORP ORD offers a dividend yield of 0.00%.

What is VCEL's Deepscope Quality Score?

Deepscope rates VCEL's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy VCEL?

Deepscope's AI Timing Score for VCEL is 29 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does VCEL belong to?

VERICEL CORP ORD is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-03 | FS: 2026-03-31)

VCEL

VERICEL CORP ORD
USD 34.74
0.29 (0.84%) Day Change
62.13
P/E
0.04
D/E
6.0%
ROE
4.4%
ROA
0.00%
Div Yield
-0.44
PEG
USD 34.74
Price
0.29 (0.84%)
Day Change
NEWS SCORE: 99

VCEL, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...

46

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
P/E ratio is relatively high
ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors 44%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 99
  Magic Formula Rank by ROA
2684
  Magic Formula Rank by ROE
2684
  Magic Formula Rank by ROIC
2732
  Price 34.74
  PBV / Sector
4.94 / 4.48
  Earning Per Share 0.42
  PE / Sector
62.13 / 16.68
  PEG or PE/Growth / Sector
-0.44 / 0.53
  Average 1M Daily Value
21.38 M
GREAT
  Average 1W Daily Value
19.23 M
GREAT
Timing Factors 42%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 45%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Ability to Make Profit 56%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
7.35 / 450.37
  NPM Average (%) / Sector
1.18 / -1,506.30
  NPM Change Average (%) / Sector
-98.88 / 4,941.44
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
4.42 / 30.83
  ROA Average (%) / Sector
0.64 / -347.12
  ROA Change Average (%) / Sector
-94.88 / 5,126.35
  ROE (%) / Sector
6.02 / -3.04
  ROE Average (%) / Sector
0.83 / 40.76
  ROE Change Average (%) / Sector
-93.81 / 2,110.63
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Return to Investors 4%
X
  Dividend (%) / Sector
N/A / 0.05
  Dividend Average (%) / Sector
N/A / 16.49
  Dividend Change Average (%) / Sector
N/A / 5.25
Registration Details
X
  Analyze Date 2026-06-04 09:24:06
  Symbol VCEL
  Name VERICEL CORP ORD
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 51.07 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 1,759.30 / 8,483.11
News, Concensus, ...
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 64 Sidney Street, Cambridge, MA, United States, 02139

Phone: 617 588 5555

Website: https://www.vcel.com

Employees: 398

Sector: Healthcare >> Biotechnology

Description: Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

ME vs SECTOR Healthcare >> Biotechnology

VCEL (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
VCEL
VCEL
USD 34.74 (0.84%)
+ Watch + Port Chart